United States (US) Oncology-Cancer Drugs Market (2025-2031) | Trends, Size & Revenue, Forecast, Outlook, Industry, Share, Analysis, Segmentation, Competitive Landscape, Growth, Companies, Value

Name: United States (US) Oncology-Cancer Drugs Market (2025-2031) | Trends & Size
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Drug Class (Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Other Cancers) And Competitive Landscape

Product Code: ETC9972040	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Dhaval Chaurasia	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Oncology-Cancer Drugs Market Outlook
Market Size of United States (US) Oncology-Cancer Drugs Market, 2024
Forecast of United States (US) Oncology-Cancer Drugs Market, 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Revenues & Volume for the Period 2021- 2031
United States (US) Oncology-Cancer Drugs Market Trend Evolution
United States (US) Oncology-Cancer Drugs Market Drivers and Challenges
United States (US) Oncology-Cancer Drugs Price Trends
United States (US) Oncology-Cancer Drugs Porter's Five Forces
United States (US) Oncology-Cancer Drugs Industry Life Cycle
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Drug Class for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Targeted Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Immunotherapy (Biologic Therapy) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Hormonal Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Lung Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Stomach Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Colorectal Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Breast Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Prostate Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Liver Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Esophagus Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Oncology-Cancer Drugs Market Revenues & Volume By Other Cancers for the Period 2021- 2031
United States (US) Oncology-Cancer Drugs Import Export Trade Statistics
Market Opportunity Assessment By Drug Class
Market Opportunity Assessment By Indication
United States (US) Oncology-Cancer Drugs Top Companies Market Share
United States (US) Oncology-Cancer Drugs Competitive Benchmarking By Technical and Operational Parameters
United States (US) Oncology-Cancer Drugs Company Profiles
United States (US) Oncology-Cancer Drugs Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Oncology-Cancer Drugs Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Oncology-Cancer Drugs Market - Industry Life Cycle

3.4 United States (US) Oncology-Cancer Drugs Market - Porter's Five Forces

3.5 United States (US) Oncology-Cancer Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Oncology-Cancer Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F

4 United States (US) Oncology-Cancer Drugs Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in the US

4.2.2 Technological advancements in oncology drug development

4.2.3 Growing investments in research and development for cancer treatments

4.3 Market Restraints

4.3.1 Stringent regulatory approvals for oncology drugs

4.3.2 High cost associated with cancer drug development and treatment

4.3.3 Growing competition among pharmaceutical companies in the oncology market

5 United States (US) Oncology-Cancer Drugs Market Trends

6 United States (US) Oncology-Cancer Drugs Market, By Types

6.1 United States (US) Oncology-Cancer Drugs Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.1.4 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F

6.1.5 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Immunotherapy (Biologic Therapy), 2021- 2031F

6.1.6 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F

6.2 United States (US) Oncology-Cancer Drugs Market, By Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Lung Cancer, 2021- 2031F

6.2.3 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Stomach Cancer, 2021- 2031F

6.2.4 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F

6.2.5 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Breast Cancer, 2021- 2031F

6.2.6 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Prostate Cancer, 2021- 2031F

6.2.7 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Liver Cancer, 2021- 2031F

6.2.8 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

6.2.9 United States (US) Oncology-Cancer Drugs Market Revenues & Volume, By Other Cancers, 2021- 2031F

7 United States (US) Oncology-Cancer Drugs Market Import-Export Trade Statistics

7.1 United States (US) Oncology-Cancer Drugs Market Export to Major Countries

7.2 United States (US) Oncology-Cancer Drugs Market Imports from Major Countries

8 United States (US) Oncology-Cancer Drugs Market Key Performance Indicators

8.1 Patient survival rates post-treatment

8.2 Adoption rates of innovative cancer therapies

8.3 Number of clinical trials for cancer drugs in the US

9 United States (US) Oncology-Cancer Drugs Market - Opportunity Assessment

9.1 United States (US) Oncology-Cancer Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Oncology-Cancer Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F

10 United States (US) Oncology-Cancer Drugs Market - Competitive Landscape

10.1 United States (US) Oncology-Cancer Drugs Market Revenue Share, By Companies, 2024

10.2 United States (US) Oncology-Cancer Drugs Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Estonia Oncology-Cancer Drugs Market

Ethiopia Oncology-Cancer Drugs Market

Fiji Oncology-Cancer Drugs Market

Finland Oncology-Cancer Drugs Market

Gabon Oncology-Cancer Drugs Market

Global Oncology-Cancer Drugs Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here